iifl-logo-icon 1

Alpa Laboratories Ltd Share Price

88.66
(0.38%)
Jul 23, 2024|10:19:54 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open89.94
  • Day's High90.85
  • 52 Wk High115
  • Prev. Close88.32
  • Day's Low88.25
  • 52 Wk Low68.1
  • Turnover (lac)10.55
  • P/E11.11
  • Face Value10
  • Book Value76.67
  • EPS7.97
  • Mkt. Cap (Cr.)186.54
  • Div. Yield0
No Records Found

Alpa Laboratories Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

89.94

Prev. Close

88.32

Turnover(Lac.)

10.55

Day's High

90.85

Day's Low

88.25

52 Week's High

115

52 Week's Low

68.1

Book Value

76.67

Face Value

10

Mkt Cap (₹ Cr.)

186.54

P/E

11.11

EPS

7.97

Divi. Yield

0

Alpa Laboratories Ltd Corporate Action

5 Sep 2023

12:00 AM

AGM

Announcement Date: 05 Sep, 2023

arrow

9 Sep 2023

12:00 AM

BookCloser

arrow

7 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Alpa Laboratories Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Alpa Laboratories Ltd SHAREHOLDING SNAPSHOT

23 Jul, 2024|10:36 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 57.29%

Foreign: 0.00%

Indian: 57.29%

Non-Promoter- 0.35%

Institutions: 0.35%

Non-Institutions: 42.34%

Custodian: 0.00%

Share Price

Alpa Laboratories Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

21.04

21.04

21.04

21.04

Preference Capital

0

0

0

0

Reserves

123.49

110.6

96.48

89.19

Net Worth

144.53

131.64

117.52

110.23

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2017Mar-2016

Revenue

97.55

85.96

63.38

53.5

yoy growth (%)

13.47

35.63

18.46

-6.78

Raw materials

-59.46

-50.99

-36.32

-27.87

As % of sales

60.95

59.31

57.3

52.1

Employee costs

-11.74

-11.82

-8.61

-7.17

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2017Mar-2016

Profit before tax

10.79

5.07

11.21

10.63

Depreciation

-1.22

-1.14

-0.76

-0.83

Tax paid

-3.52

-0.99

-3.11

-2.89

Working capital

12.44

-45.41

-11.88

-8.27

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2017Mar-2016

Growth matrix (%)

Revenue growth

13.47

35.63

18.46

-6.78

Op profit growth

123.3

-51.39

4.2

99.33

EBIT growth

106.38

-59.18

7.04

8,435.12

Net profit growth

78.13

-31.91

-22.6

-654.09

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

108.74

92.44

112.27

97.55

85.97

Excise Duty

0

0

0

0

0

Net Sales

108.74

92.44

112.27

97.55

85.97

Other Operating Income

0

0

0

0

0

Other Income

14.89

9.93

10.78

4.4

2.91

Alpa Laboratories Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,587.35

124.833,80,990.4867.60.855,536.9998.75

Divis Laboratories Ltd

DIVISLAB

4,534.8

76.421,20,383.365310.662,259507.93

Cipla Ltd

CIPLA

1,490

32.381,20,295.961,038.40.573,444.92346.41

Zydus Lifesciences Ltd

ZYDUSLIFE

1,154.55

33.791,16,159.651,405.20.263,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,770.9

26.361,12,931.21,034.80.595,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Alpa Laboratories Ltd

Management

Register Office

Registrar Office

Chairman & Exec. Director

Mahendra Singh Chawla

Executive Director

Pravin C Shah

Independent Director

Sharad Chand Lunawat

Independent Director

Devendra Baheti

Independent Director

Krishna Das Malani

Managing Director

Paresh Chawla

Independent Director

Jyoti Jain

Company Sec. & Compli. Officer

Swati Bagh

Executive Director

Vitthal Kothana

Additional Director

SUNIL VALECHA

Independent Director

Saket Baheti

Independent Director

Pratibha Lunawat

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

M/s Alpa Laboratories, formed in 1967, was incorporated as Private Limited Company in the name of Alpa Laboratories Private Limited on March 18, 1988 for manufacture of pharmaceutical formulations. In 1998, the Company was converted into a Public Limited Company with effect from September 3, 1998 with the name of Alpa Laboratories Limited. The facility has dedicated manufacturing areas for different Finished Dosage Forms (FDFs) including liquid injections, dry injections, tablets, capsules, eye drops, ear drops, ointments, creams and gels.In 1997, the company has initiated setting of a new manufacturing unit at Rau(Indore District), Madhya Pradesh. The unit commenced commercial production in the year 1999 of all types of formulations viz. Injectables (Vials/Ampoules both liquid and Dry), tablets, capsules, eye/ear drops, ointment and creams. The company has manufacture a range of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products in various dosage forms and market them under the trade mark Alpa which is a registered trademark in the name of Alpa Labs (India) Limited, a promoter group company. The company has also manufacture formulations for a number of other pharmaceutical companies of national and international repute such as Cipla, Zydus Cadila, Lupin, Glenmark, Genom Biotech, Jenburkt, etc. (under their own brands) located both in India and abroad in countries such as Philippines, Iran, Iraq, Sierra Leon, Madagascar, Kenya,
Read More

Company FAQs

What is the Alpa Laboratories Ltd share price today?

Down Arrow

The Alpa Laboratories Ltd shares price on N/A is Rs.₹89.15 today.

What is the Market Cap of Alpa Laboratories Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Alpa Laboratories Ltd is ₹187.57 Cr. as of 23 Jul ‘24

What is the PE and PB ratio of Alpa Laboratories Ltd?

Down Arrow

The PE and PB ratios of Alpa Laboratories Ltd is 11.11 and 1.15 as of 23 Jul ‘24

What is the 52 Week High and Low of Alpa Laboratories Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Alpa Laboratories Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Alpa Laboratories Ltd is ₹68.3 and ₹115 as of 23 Jul ‘24

What is the CAGR of Alpa Laboratories Ltd?

Down Arrow

Alpa Laboratories Ltd's CAGR for 5 Years at 31.88%, 3 Years at 20.71%, 1 Year at 28.22%, 6 Month at -11.58%, 3 Month at -4.90% and 1 Month at -1.61%.

What is the shareholding pattern of Alpa Laboratories Ltd?

Down Arrow

The shareholding pattern of Alpa Laboratories Ltd is as follows:
Promoters - 57.29 %
Institutions - 0.36 %
Public - 42.35 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.